Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-term prognosis?

Table 2 Morbidity and mortality

		transhiatal (TH)			transthoracic (TT)			p-value
duration of surgery	median (range)	254	(160–485)		335	(240–540)		<0.0005
(min)								U-test
blood loss	median (range)	800	(0–7500)		1000	(200–5000)		0.002
(ml) intraoperatively								U-test
blood substitution	median (range)	0	(0–6)		1	(0–14)		0.128
(PRBC) intraoperatively								U-test
surgical complications		44	103	42.7%	7	47	14.9%	0.001
								Fisher
general complications		22	102	21.6%	20	47	42.6%	0.011
								Fisher
total complications		62	103	60.2%	25	47	53.2%	0.477
								Fisher
duration of postoperative intensive care unit stay
(days)	median (range)	8	(2–107)		8	(1–97)		0.566
								U-test
duration of postoperative in-hospital stay
(days)	median (range)	21	(14–126)		20	(13–107)		0.646
hospital mortality		3	103	2.9%	7	47	14.9%	0.011
								Fisher
30-day mortality		2	100	2.0%	7	47	14.9%	0.005
								Fisher

ISSN: 1477-7819